Diligence memo · auto-generated · as of July 3, 2026
IdentifySensors Biologics Corp.
IdentifySensors Biologics Corp. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
IdentifySensors Biologics Corp. operates in Biotech / Pharma, based in SHAKER HEIGHTS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
IdentifySensors Biologics Corp. has raised $2.1M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.3M on 2023-12-23.
Most recent recorded round closed around 2023-12-23.
Valuation (modeled)modeled
Provath models IdentifySensors Biologics Corp. at approximately $8.0M (range $923K–$24M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.46× the median modeled value of Seed Biotech / Pharma companies in 2022–2024 (14 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 33 months.
Last raise 2.5 yr ago; this sector typically re-raises about every 15 months.
Slightly overdue versus sector cadence.
The last round stepped up 1.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 37% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 31% of those peers.
Closest niche peers: Outer Biosciences, LLC, Slate Bio, Inc., CASS Pharmaceuticals, Inc., FOOP Organic Biosciences, Inc., Trio Pharmaceuticals, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.